Dual GIP/GLP-1 agonists now represent the highest-revenue growth segment in the GLP-1 weight loss drug market at 18.4% CAGR , with tirzepatide generating USD 18.3 billion in 2025 revenue through Zepbound and Mounjaro surpassing Eli Lillys entire insulin franchise within two years of commercial launch
Naturally, carnitine is also crucial for athletes with increased demands, whether for exercise performance or body composition goals
How to Administer Retatrutide is administered via subcutaneous (SubQ) injection , meaning it goes just under the skin, not into muscle
Bottom Line Current data on GLP-1 receptor agonists and addiction is certainly promising
Insulin-like growth factor (IGF) system components in human prostatic cancer cell-lines: LNCaP, DU145, and PC-3 cells
GHK-Cu has shown protective effects on cartilage and bone cells in vitro, suggesting potential in joint or bone healing